Labcorp
Precio: 265.27Empresa y modelo de negocio
Labcorp is a leading healthcare company that provides comprehensive laboratory services and diagnostic solutions. Its core offerings include clinical laboratory testing, drug development services, and genomic testing. The company operates in two major segments: Labcorp Diagnostics and Labcorp Drug Development. Major revenue sources stem from clinical testing services for healthcare providers and pharmaceutical companies, as well as from its extensive portfolio of laboratory tests and clinical trials.
Perfil de inversión
The investment profile of Labcorp is more aligned with value investors, given its stable revenue generation and modest dividend yield. The stock may appeal to those seeking consistent performance rather than aggressive growth, reflecting a balanced approach to risk and potential returns.
Métricas fundamentales
- EPS (TTM) — ganancias por acción de los últimos 12 meses, $
- 11.37 OK
- Ingresos QoQ — crecimiento trimestral de ingresos
- 0.6% ≈
- Sorpresa EPS
- 3.0% en línea
- Volatilidad 20d
- 1.1% estable
- Rendimiento de dividendos
- 1.1% moderado última fecha ex-div.: 2026-05-29
Seguir en portafolio
Gráfico de precio
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-06-10 00:48 | Mantener | Comprar | Strong performance and solid fundamentals support growth potential. |
| 2026-05-24 02:44 | Vender | Mantener | Mixed performance; cautious outlook amid market conditions. |
| 2026-05-16 02:42 | Mantener | Vender | Weak momentum and fundamentals raise significant risk. |
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-05-01 12:49 | Robert W. Baird | Objetivo aumentado | 332 → 334 | 255.97 |
| 2026-04-08 13:14 | Evercore ISI | Objetivo aumentado | 280 → 300 | 274.72 |
| 2026-02-24 11:40 | Piper Sandler | Objetivo aumentado | 270 → 300 | 285.3 |
Nada todavía